Protecting health: Active generic and biosimilar policies central to EU pharmaceutical strategy

3 March 2020

Equitable and sustainable access to medicines is a concern across […]

Impact of COVID-19 on active ingredient and medicines manufacturing and supplies in Europe

18 February 2020

Resolving and mitigating medicine shortages in the EU

10 February 2020

Drug shortages can greatly impact patients and the pharmaceutical industry. […]

The European Medicines Verification System (EMVS) celebrates 1 year of successful operation across Europe

7 February 2020

Arun Narayan – Chairman, Value Added Medicines Group, Medicines for Europe

31 January 2020

Arun Narayan is the Chairman of the Value Added Medicines […]

Time to modernise the EU pharmaceutical regulatory framework to deliver on access

30 January 2020

To maintain its leadership in pharmaceutical regulatory science, the EU […]

Smart Pharmacovigilance Essential for Patient Safety

29 January 2020

Medicines are developed and manufactured to help patients so, it […]

Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards

16 January 2020

Since the first treatment was approved in 2006, Europe has […]

AMR life science industry 2020 report: Successes and setbacks in fighting superbugs

16 January 2020

Hanan Sboul takes over the position of IGBA Chair

7 January 2020